You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Light chain Multiple Myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Multiple Myeloma, Amyloid Light-chain Amyloidosis Trial (SAR445514)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Amyloid Light-chain Amyloidosis
  • (no location specified)
Apr 20, 2023

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

Active, not recruiting
  • Multiple Myeloma
  • AL Amyloidosis
  • Siltuximab
  • The M.D. Anderson Symptom Inventory (MDASI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

Suspended
  • Amyloid
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
May 17, 2022

Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)

Active, not recruiting
  • Multiple Myeloma
  • Amyloidosis
  • Melphalan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
Has Results
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Recruiting
  • Multiple Myeloma
  • +11 more
  • No intervention
  • Beijing, China
    Peking University First Hospital
Apr 21, 2022

Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill

Recruiting
  • Multiple Myeloma
  • +8 more
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital
    Nov 30, 2021

    Multiple Myeloma, Amyloidosis Trial in Jacksonville, New York, Cleveland (APG-2575+ Pd, APG-2575 + DRd)

    Recruiting
    • Multiple Myeloma
    • Amyloidosis
    • APG-2575+ Pd
    • APG-2575 + DRd
    • Jacksonville, Florida
    • +2 more
    Feb 28, 2022

    Screening to Improve Survival in AL Amyloidosis

    Recruiting
    • Smoldering Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
      • Orange, California
      • +5 more
      Nov 16, 2022

      Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

      Recruiting
      • Multiple Myeloma
      • +2 more
      • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Apr 12, 2022

      Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

      Recruiting
      • Lymphoma
      • +2 more
      • Kappa CD28 T cells
      • Houston, Texas
      • +1 more
      Jan 31, 2022

      Duration of Treatment and Response in Multiple Myeloma or

      Recruiting
      • Multiple Myeloma
      • Immunoglobulin Light-chain Amyloidosis
        • Cadiz, Andalucia, Spain
        • +13 more
        Dec 21, 2021

        Multiple Myeloma-Light Chain Only, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (drug,

        Terminated
        Has Results
        • Multiple Myeloma-Light Chain Only
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 9, 2021

        Multiple Myeloma Trial in New York (Circadian Effective Lighting, Circadian Ineffective Lightning (CIL))

        Recruiting
        • Multiple Myeloma
        • Circadian Effective Lighting
        • Circadian Ineffective Lightning (CIL)
        • New York, New York
        • +1 more
        Feb 10, 2023

        Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and

        Not yet recruiting
        • Multiple Sclerosis
        • Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic plasmacytoid Dendritic Cells
        • (no location specified)
        Oct 10, 2022

        Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

        Recruiting
        • Recurrent Plasma Cell Myeloma
        • Refractory Plasma Cell Myeloma
        • Atlanta, Georgia
          Emory University Hospital/Winship Cancer Institute
        Jan 24, 2023

        CSF Free Kappa Light Chain for The Diagnosis of Demyelinating

        Completed
        • Multiple Sclerosis
        • Kappa Free Light Chain (K-FLC)
        • Karachi, Sindh, Pakistan
          Clinical Chemistry, Sopari wala building
        Apr 20, 2022

        Samples and Clinical Data From Patients With Amyloid Diseases

        Recruiting
        • Multiple Myeloma
        • clonality analysis
        • +6 more
        • Boston, Massachusetts
          Boston University Cancer Research Center
        Jan 28, 2023

        AL Amyloidosis, Plasma Cell Dyscrasia Trial in Nanjing

        Enrolling by invitation
        • AL Amyloidosis
        • Plasma Cell Dyscrasia
          • Nanjing, Jiangsu, China
            National Clinical Research Center of Kidney Diseases, Jinling Ho
          Jan 26, 2021

          Multiple Myeloma Trial in San Francisco (Free light chains)

          Recruiting
          • Multiple Myeloma
          • Free light chains
          • San Francisco, California
            San Francisco General Hospital
          Mar 23, 2022

          Multiple Sclerosis, Relapsing-Remitting Trial in Switzerland (serum Neurofilament Filament Light chain (sNfL) monitoring)

          Not yet recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • serum Neurofilament Filament Light chain (sNfL) monitoring
          • Basel, Basel Stadt, Switzerland
          • +7 more
          Oct 17, 2023

          Multiple Sclerosis Trial in Brussels (Visual Evoked Potential (VEP), Somatosensory evoked potential (SSEP), Transcranial

          Recruiting
          • Multiple Sclerosis
          • Visual Evoked Potential (VEP)
          • +5 more
          • Brussels, Belgium
            CHU Brugmann
          Jul 4, 2023

          Healthy Volunteers of Fanconi Anemia, Myeloproliferative

          Completed
          • Chronic Myeloproliferative Disorders
          • +3 more
          • microarray analysis
          • +8 more
          • Portland, Oregon
            Knight Cancer Institute at Oregon Health and Science University
          Jun 30, 2022

          Light Chain Deposition Disease (LCDD or MIDD), Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD), Monoclonal

          Completed
          Has Results
          • Light Chain Deposition Disease (LCDD or MIDD)
          • +3 more
          • Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
          • Basking Ridge, New Jersey
          • +4 more
          Mar 30, 2020